An early agenda item for Tata Sons Pvt.s six board directors when they convened at 11:30 a.m. on Tuesday at Bombay House the groups storied headquarters was expected to be straightforward: approving a third term for Natarajan Chandrasekaran as chairman.
Public sector banks are showing resilience in their loan-to-deposit ratios, with a significant gap compared to private peers. Despite concerns, PSU banks are leading credit growth and demonstrating improved asset quality and return on equity, suggesting a positive near-term outlook.
Biocon CEO Siddharth Mittal outlines the company's strategy in the competitive GLP-1 market. Focusing on liraglutide's launch in the US and Europe, he highlights opportunities in emerging markets. While semaglutide is a longer-term play, Biocon is actively filing for approvals, anticipating launches in 2027.
Indian IT stocks experienced a significant downturn due to AI concerns, with the Nifty IT index falling 21% in February. However, 25 select stocks defied the slump, showing positive returns by focusing on AI infrastructure, integration, and specialized engineering, indicating potential future growth themes for the sector.
